2007Shiyong yixue zazhiRequires access

Comparison of cardiac troponin I with CK-MB in the diagnosis of myocardial injury in children

Zheng Xiao-qin

Open publisher page 0 citations

Abstract

Objective To determine the impacts of various pathological changes on serum cardiac troponin I (cTnI) levels and creatine kinase MB isoenzyme (CK-MB) activity and to compare the diagnostic values of cTnI with that of CK-MB. Methods Serum cTnI levels and CK-MB activity were measured in four groups of children. Group A included 54 healthy children as control. Group B included 53 pediatric patients without cardiac diseases. Group C included 12 pediatric patients with stable congenital heart diseases. Group D included 14 pediatric patients with acute myocarditis. Results The cTnI levels were all less than 0.25 μg/mL in group A and there were no significant differences among the subgroups of different ages. CK-MB was increased in one patient (1.9%). cTnI did not differ significantly among groups A, B, and C. One patient (1.9%) had elevated cTnI and nine patients (16.9%) had higher CK-MB in group B. No increase in cTnI occurred in group C whereas CK-MB was elevated in one patient (8.3%). cTnI in group D was increased in 11 patients and its mean value was markedly higher than that in group A (P 0.01). Conclusion cTnI can be used to diagnose myocardial injury in children with a high specificity and sensitivity. No elevation in cTnI occurred in the children who have no cardiovascular diseases. CK-MB activity, however, can be affected by other disorders besides cardiovascular diseases.

About this research paper

What this paper is about

Objective To determine the impacts of various pathological changes on serum cardiac troponin I (cTnI) levels and creatine kinase MB isoenzyme (CK-MB) activity and to compare the diagnostic values of cTnI with that of CK-MB. Methods Serum cTnI levels and CK-MB activity were measured in four groups of children. Group A included 54 healthy children as control. Group B included 53 pediatric patients without cardiac diseases. Group C included 12 pediatric patients with stable congenital heart diseases. Group D included 14 pediatric patients with acute myocarditis. Results The cTnI levels were all less than 0.25 μg/mL in group A and there were no significant differences among the subgroups of different ages. CK-MB was increased in one patient (1.9%). cTnI did not differ significantly among groups A, B, and C. One patient (1.9%) had elevated cTnI and nine patients (16.9%) had higher CK-MB in group B. No increase in cTnI occurred in group C whereas CK-MB was elevated in one patient (8.3%). cTnI in group D was increased in 11 patients and its mean value was markedly higher than that in group A (P 0.01). Conclusion cTnI can be used to diagnose myocardial injury in children with a high specificity and sensitivity. No elevation in cTnI occurred in the children who have no cardiovascular diseases. CK-MB activity, however, can be affected by other disorders besides cardiovascular diseases.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To determine the impacts of various pathological changes on serum cardiac troponin I (cTnI) levels and creatine kinase MB isoenzyme (CK-MB) activity and to compare the diagnostic values of cTnI with that of CK-MB. Methods Serum cTnI levels and CK-MB activity were measured in four groups of children. Group A included 54 healthy children as control. Group B included 53 pediatric patients without cardiac diseases. Group C included 12 pediatric patients with stable congenital heart diseases. Group D included 14 pediatric patients with acute myocarditis. Results The cTnI levels were all less than 0.25 μg/mL in group A and there were no significant differences among the subgroups of different ages. CK-MB was increased in one patient (1.9%). cTnI did not differ significantly among groups A, B, and C. One patient (1.9%) had elevated cTnI and nine patients (16.9%) had higher CK-MB in group B. No increase in cTnI occurred in group C whereas CK-MB was elevated in one patient (8.3%). cTnI in group D was increased in 11 patients and its mean value was markedly higher than that in group A (P 0.01). Conclusion cTnI can be used to diagnose myocardial injury in children with a high specificity and sensitivity. No elevation in cTnI occurred in the children who have no cardiovascular diseases. CK-MB activity, however, can be affected by other disorders besides cardiovascular diseases.

Key concepts: Troponin I, Medicine, Internal medicine, Cardiology, Creatine kinase, Troponin, Myocarditis, Pathological

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparison of cardiac troponin I with CK-MB in the diagnosis of myocardial injury in children — Research Paper | ScholarLens